OSTEOTECH INC|4Nov 16, 3:50 PM ET

FALLON KENNETH P III 4

4 · OSTEOTECH INC · Filed Nov 16, 2010

Form 4

Period: 2010-11-16

Director

Transactions

Disposition to Issuer
Common Stock
2010-11-16−46,500→ 0 total
Disposition to Issuer
Stock Option (Right to Buy)
2010-11-16$6.50/sh−15,000$97,500→ 0 total
Exercise: $3.33Exp: 2015-06-09→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2010-11-16$6.50/sh−100,000$650,000→ 0 total
Exercise: $4.74Exp: 2019-07-01→ Common Stock (100,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2010-11-16$6.50/sh−11,250$73,125→ 0 total
Exercise: $6.92Exp: 2012-06-13→ Common Stock (11,250 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2010-11-16$6.50/sh−15,000$97,500→ 0 total
Exercise: $6.52Exp: 2014-06-10→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2010-11-16$6.50/sh−11,250$73,125→ 0 total
Exercise: $4.95Exp: 2011-06-14→ Common Stock (11,250 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2010-11-16$6.50/sh−15,000$97,500→ 0 total
Exercise: $13.45Exp: 2013-06-12→ Common Stock (15,000 underlying)

Footnotes (3)

[F1]In connection with the merger of a subsidiary of Medtronic, Inc. into Issuer on November 16, 2010 (the "Merger") pursuant to an agreement and plan of merger dated August 16, 2010, all shares of Issuer common stock were canceled and automatically converted into the right to receive $6.50 per share in cash, without interest and less any applicable withholding taxes.
[F2]Pursuant to the Merger, this option was canceled in exchange for right to receive a cash payment equal to the total number of shares of common stock subject to the option multiplied by the excess, if any, of $6.50 per share over the exercise price of the option, less any applicable withholding taxes.
[F3]The option reported herein was fully exercisable prior to the date of the Merger.

Documents

1 file